ConductScience.org, home

Paper22017885

Ports and complications for intraperitoneal chemotherapy delivery.

Helm CW. BJOG, 2012. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Ports and complications for intraperitoneal chemotherapy delivery. Papers, record 22017885. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22017885

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ports and complications for intraperitoneal chemotherapy delivery.
PubMed
Journal
BJOG
PubMed
Year
2012
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
0.75
iCite
Revised in PubMed
2011-12-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Helm CWC W

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Catheters, IndwellingMajor topic
Ovarian NeoplasmsMajor topic
Clinical Competence
Device Removal
Equipment Contamination
Equipment Failure
Female
Gynecology
Humans
Infusions, Parenteral
Intestinal Perforation
Intestine, Large
Intestine, Small
Pain
Peritoneal Cavity
Time Factors

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
41827699The New Era of Intraperitoneal Carboplatin in Ovarian Cancer: From Biological Rationale to Clinical Implementation.Cancers (Basel)2026https://conductscience.org/library/papers/41827699PubMed
40855029Physiological Considerations and Delivery Strategies for Targeting Tumors Through Intraperitoneal Delivery.Pharm Res2025https://conductscience.org/library/papers/40855029PubMed
39183486Long-term intraperitoneal access with description of a new access catheter.J Surg Oncol2024https://conductscience.org/library/papers/39183486PubMed
35242186Hyperthermic Intraperitoneal Chemotherapy plus Intravenous Chemotherapy of Paclitaxel with or without Sintilimab in Gastric Cancer: A Comparative Study.J Oncol2022https://conductscience.org/library/papers/35242186PubMed
31103675Enhanced anti-tumor efficacy and safety with metronomic intraperitoneal chemotherapy for metastatic ovarian cancer using biodegradable nanotextile implants.J Control Release2019https://conductscience.org/library/papers/31103675PubMed
30911623Morphology of the peritoneal cavity and pathophysiological consequences.Pleura Peritoneum2016https://conductscience.org/library/papers/30911623PubMed
29782365
Utilization of an Alternative Docetaxel-based Intraperitoneal Chemotherapy Regimen in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma: A Continued Need for Ovarian Cancer Patients.
Am J Clin Oncol2019https://conductscience.org/library/papers/29782365PubMed
28483269Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study.Gynecol Oncol2017https://conductscience.org/library/papers/28483269PubMed
27720232Distance from a Comprehensive Cancer Center: A proxy for poor cervical cancer outcomes?Gynecol Oncol2016https://conductscience.org/library/papers/27720232PubMed
27189456
Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center.
Gynecol Oncol2016https://conductscience.org/library/papers/27189456PubMed
25207212Management of recurrent epithelial ovarian cancer.Gland Surg2014https://conductscience.org/library/papers/25207212PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22017885

GET https://conductscience.org/api/papers/v1/22017885/authors